GlassScriptPhysician profile
Omar I Madriz
NPI 1598871204
$4,298.61
in general payments reported to CMS, 2019-2025
17 companies · $887 in 2025
The $887 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $48.72 · 2021: $197 · 2022: $1,365 · 2023: $656 · 2024: $549 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,091.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,341.91 | 2020-2025 | |
| Thd America, INC. | $578.29 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $421.51 | 2019-2025 | Exparel |
| Baxter Healthcare | $310.94 | 2024-2025 | Perclot, Tisseel |
| Medtronic, INC. | $257.89 | 2023-2025 | Signia, Surgipro Ll |
| Becton, Dickinson and Company | $202.24 | 2024 | Hemosphere |
| Ethicon US, LLC | $187.30 | 2019-2024 | Ethicon, Vistaseal, Surgicel Nu-Knit |
| Aroa Biosurgery Incorporated | $167.05 | 2025 | |
| Stryker Corporation | $146.80 | 2019 | |
| Davol INC. | $139.66 | 2023 | Arista Ah Flexitip |
| Vertex Pharmaceuticals Incorporated | $109.83 | 2025 | |
| Boston Scientific Corporation | $106.30 | 2019 | |
| Shire North American Group INC | $105.79 | 2019 | |
| Convatec INC. | $105.20 | 2022 | |
| Tela Bio, INC. | $93.34 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aries Pharmaceuticals, INC. | $13.58 | 2019 | |
| Kerecis Limited | $10.98 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Madriz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.